Clinical Trials Directory

Trials / Completed

CompletedNCT01993238

Evaluation of Procedural Analgesia for Liposonix Treatment

An Evaluation of Procedural Analgesia for Out-Patient Liposonix Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Solta Medical · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objectives of this study are to evaluate the safety and effectiveness of procedural analgesia for improvements in tolerability of treatment with the Liposonix System.

Conditions

Interventions

TypeNameDescription
DEVICELiposonix System (Model 2)Treatment of subcutaneous adipose tissue of the abdomen using high intensity focused ultrasound (Liposonix System Model 2).
DRUGPre-treatment analgesiaPre-treatment analgesia (combination of ondansetron, ketorolac, and hydromorphone)

Timeline

Start date
2013-11-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2013-11-25
Last updated
2014-04-29
Results posted
2014-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01993238. Inclusion in this directory is not an endorsement.

Evaluation of Procedural Analgesia for Liposonix Treatment (NCT01993238) · Clinical Trials Directory